These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18991035)

  • 21. [A prospective, observational, all-prescribed-patients study of cyclosporine 0.1% ophthalmic solution in the treatment of vernal keratoconjunctivitis].
    Takamura E; Uchio E; Ebihara N; Okamoto S; Kumagai N; Shoji J; Nakagawa Y; Namba K; Fukushima A; Fujishima H; Miyazaki D; Ohashi Y
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):508-15. PubMed ID: 21735754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P; Kosrirukvongs P
    Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
    Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
    Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [0.05% cyclosporine a for treatment of chronic severe ocular surface disease].
    Nochez Y; Denoyer A; Pisella PJ
    Can J Ophthalmol; 2009 Aug; 44(4):406-11. PubMed ID: 19606161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2019; 27(7):1184-1193. PubMed ID: 30189151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.
    Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M
    Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.
    el-Asrar AM; Tabbara KF; Geboes K; Missotten L; Desmet V
    Am J Ophthalmol; 1996 Feb; 121(2):156-61. PubMed ID: 8623884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis.
    Bremond-Gignac D; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Leonardi A;
    Am J Ophthalmol; 2020 Apr; 212():116-126. PubMed ID: 31770513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.
    Salami E; Righetti G; Cavarzeran F; Leonardi A
    Ocul Immunol Inflamm; 2023 Nov; 31(9):1870-1872. PubMed ID: 35914313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis.
    Erdinest N; Noyman DBE; London N; Lavy I; Levinger N; Landau D; Solomon A; Morad Y; Naroo SA
    Int Ophthalmol; 2024 Mar; 44(1):157. PubMed ID: 38522059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].
    Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T
    J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
    Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis.
    Kumari R; Saha BC; Sinha BP; Mohan N
    Nepal J Ophthalmol; 2017 Jul; 9(18):128-135. PubMed ID: 29634701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.